Your browser doesn't support javascript.
loading
Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy.
Sekiguchi, Shuhei; Tsuchiya, Kaoru; Yasui, Yutaka; Inada, Kento; Kirino, Sakura; Yamashita, Koji; Hayakawa, Yuka; Osawa, Leona; Higuchi, Mayu; Takaura, Kenta; Maeyashiki, Chiaki; Kaneko, Shun; Tamaki, Nobuharu; Nakanishi, Hiroyuki; Itakura, Jun; Takahashi, Yuka; Asahina, Yasuhiro; Okamoto, Ryuichi; Kurosaki, Masayuki; Izumi, Namiki.
Afiliación
  • Sekiguchi S; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino-shi, Japan.
  • Tsuchiya K; Department of Gastroenterology and Hepatology, Tokyo Medical Dental University, Bunkyo-Ku, Japan.
  • Yasui Y; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino-shi, Japan.
  • Inada K; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino-shi, Japan.
  • Kirino S; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino-shi, Japan.
  • Yamashita K; Department of Gastroenterology and Hepatology, Tokyo Medical Dental University, Bunkyo-Ku, Japan.
  • Hayakawa Y; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino-shi, Japan.
  • Osawa L; Department of Gastroenterology and Hepatology, Tokyo Medical Dental University, Bunkyo-Ku, Japan.
  • Higuchi M; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino-shi, Japan.
  • Takaura K; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino-shi, Japan.
  • Maeyashiki C; Department of Gastroenterology and Hepatology, Tokyo Medical Dental University, Bunkyo-Ku, Japan.
  • Kaneko S; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino-shi, Japan.
  • Tamaki N; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino-shi, Japan.
  • Nakanishi H; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino-shi, Japan.
  • Itakura J; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino-shi, Japan.
  • Takahashi Y; Department of Gastroenterology and Hepatology, Tokyo Medical Dental University, Bunkyo-Ku, Japan.
  • Asahina Y; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino-shi, Japan.
  • Okamoto R; Department of Gastroenterology and Hepatology, Tokyo Medical Dental University, Bunkyo-Ku, Japan.
  • Kurosaki M; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino-shi, Japan.
  • Izumi N; NAFLD Research Center, Department of Medicine, University of California San Diego, La Jolla, California, USA.
Cancer Rep (Hoboken) ; 5(11): e1613, 2022 11.
Article en En | MEDLINE | ID: mdl-35302279
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Cancer Rep (Hoboken) Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Cancer Rep (Hoboken) Año: 2022 Tipo del documento: Article País de afiliación: Japón